Basic Information
BioNumerik Pharmaceuticals, Inc. is dedicated to the discovery, development, and commercialization of drugs aimed at helping treat cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in the late stages of clinical development.
BioNumerik Pharmaceuticals Inc.
Scottsdale,Arizona,United States of America
51~100 people
January 01, 1992
Info@bnpi.com
Enterprise Profile
Industrial Sector
Concept